We are live on ! Find out more
MSA

Marino Stram & Associates Portfolio holdings

AUM $628M
1-Year Est. Return 23.07%
This Fund
S&P 500
This Quarter Est. Return
-6.29%
1 Year Est. Return
+23.07%
3 Year Est. Return
+63.64%
5 Year Est. Return
+76.05%
10 Year Est. Return
AUM
$277M
AUM Growth
-$11.3M
Cap. Flow
+$8.52M
Cap. Flow %
3.07%
Top 10 Hldgs %
59.24%
Holding
149
New
5
Increased
95
Reduced
31
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 6.97%
2 Technology 5.63%
3 Consumer Staples 4.82%
4 Financials 4.4%
5 Utilities 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYM icon
1
Vanguard High Dividend Yield ETF
VYM
$80.9B
$43M 15.51%
452,945
+30,417
+7% +$3.16M
SDY icon
2
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$28M 10.12%
251,499
+13,968
+6% +$1.72M
IVV icon
3
iShares Core S&P 500 ETF
IVV
$878B
$26.1M 9.43%
72,845
+1,965
+3% +$785K
VTV icon
4
Vanguard Morningstar Value ETF
VTV
$188B
$16.3M 5.89%
132,154
+10,522
+9% +$1.42M
IJR icon
5
iShares Core S&P Small-Cap ETF
IJR
$109B
$11M 3.97%
126,256
-1,339
-1% -$130K
VUG icon
6
Vanguard Morningstar Growth ETF
VUG
$220B
$10.9M 3.94%
306,144
+15,528
+5% +$624K
IJH icon
7
iShares Core S&P Mid-Cap ETF
IJH
$122B
$10.5M 3.81%
240,560
-2,350
-1% -$114K
AAPL icon
8
Apple
AAPL
$4.54T
$7.25M 2.62%
52,435
+1,125
+2% +$177K
JNJ icon
9
Johnson & Johnson
JNJ
$618B
$6.01M 2.17%
36,786
+427
+1% +$72.3K
MSFT icon
10
Microsoft
MSFT
$3.45T
$4.98M 1.8%
21,399
+2,371
+12% +$626K
AOR icon
11
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$3.81M 1.37%
85,093
+13,238
+18% +$641K
MRK icon
12
Merck
MRK
$322B
$3.09M 1.12%
35,932
+294
+0.8% +$26.2K
PEP icon
13
PepsiCo
PEP
$190B
$2.97M 1.07%
18,167
+150
+0.8% +$25.9K
IDV icon
14
iShares International Select Dividend ETF
IDV
$8.45B
$2.96M 1.07%
131,299
-5,431
-4% -$143K
JPM icon
15
JPMorgan Chase
JPM
$935B
$2.9M 1.05%
27,763
+831
+3% +$95.4K
PFE icon
16
Pfizer
PFE
$143B
$2.83M 1.02%
64,614
+851
+1% +$41.4K
LMT icon
17
Lockheed Martin
LMT
$134B
$2.46M 0.89%
6,359
+155
+2% +$64.7K
PG icon
18
Procter & Gamble
PG
$336B
$2.4M 0.87%
19,038
+418
+2% +$59.4K
NULV icon
19
Nuveen ESG Large-Cap Value ETF
NULV
$2.19B
$2.33M 0.84%
75,386
+5,114
+7% +$175K
MCD icon
20
McDonald's
MCD
$192B
$2.29M 0.83%
9,920
+78
+0.8% +$19.9K
VZ icon
21
Verizon
VZ
$195B
$2.26M 0.82%
59,623
+803
+1% +$35.8K
VIG icon
22
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.26M 0.82%
16,729
-558
-3% -$83K
KO icon
23
Coca-Cola
KO
$377B
$2.15M 0.78%
38,422
+843
+2% +$52.4K
USMV icon
24
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
$2.15M 0.78%
32,524
-745
-2% -$53.7K
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.07M 0.75%
7,760
-20
-0.3% -$5.69K

Similar funds

Marino Stram & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Marino Stram & Associates held 149 positions worth $277M, down 3.9% from $288M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Marino Stram & Associates deployed $8.52M of net new capital in Q3 2022, opening 5 new positions and adding to 95 existing holdings. Its largest new stake was T. Rowe Price: 2,083 shares worth $219K.

By sector, the portfolio is most concentrated in Healthcare at 7% of assets, down from 7.3% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Boeing, an estimated $368K trimmed.

  • Marino Stram & Associates's largest Q3 2022 buy was T. Rowe Price: 2,083 shares worth $219K.
  • Marino Stram & Associates added most to Vanguard High Dividend Yield ETF in Q3 2022, an estimated $3.16M increase.
  • Marino Stram & Associates's biggest Q3 2022 reduction was Boeing, cutting an estimated $368K.
  • Marino Stram & Associates fully exited SPDR Gold MiniShares Trust in Q3 2022, selling an estimated $910K.
  • Marino Stram & Associates's ten largest holdings make up 59% of its $277M portfolio in Q3 2022.
  • Marino Stram & Associates opened 5 new positions and closed 9 in Q3 2022.
  • Marino Stram & Associates's portfolio value fell 3.9% quarter-over-quarter to $277M.

Based on Marino Stram & Associates's 13F filing for Q3 2022, filed 17 Oct 2022.